Skip to main content
SpringerLink
Log in
Book cover

Epidemiologic Studies in Cancer Prevention and Screening pp 349–381Cite as

Integrating Prevention and Screening for Lung Cancer into Clinical Practice

  • Chapter
  • First Online:

  • 1582 Accesses

Part of the book series: Statistics for Biology and Health ((SBH,volume 79))

Abstract

Lung cancer is the leading cause of cancer mortality worldwide. When diagnosed at an early stage, lung cancer 5-year survival is 60–70 %, but when diagnosed clinically, most cancers are advanced and overall 5-year survival is 16 %. Exposure to tobacco smoke is the dominant risk factor, but other environment and host factors are also important. Lung cancer prevention and early detection through screening have the potential to reduce lung cancer morbidity and mortality. Risk prediction models can be helpful in defining target populations for both prevention and screening. Prevention is currently based on avoidance of tobacco use and exposure. There are no established chemoprevention agents for lung cancer, but this remains an area of active investigation. The National Lung Screening Trial (NLST) demonstrated for the first time that screening with low-dose computed tomography (LDCT) reduces lung cancer mortality among a high-risk population. Efforts to better define the optimal approach to screening and the development of lung cancer screening guidelines are now underway. Discovery of biomarkers capable of detecting lung cancer at an early stage is another area of great promise. The combination of LDCT and biomarkers in the future should help improve the accuracy and clinical utility of screening programs. All screening programs should incorporate access to tobacco cessation resources.

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   129.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD   109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

References

  • Alberg AJ, Brock MV, Samet JM. Epidemiology of lung cancer: looking to the future. J Clin Oncol 2005; 23:3175-3185.

    Article  Google Scholar 

  • Alavanja MC. Biologic damage resulting from exposure to tobacco smoke and from radon: implication for preventive interventions. Oncogene 2002; 21:7365-7375.

    Article  Google Scholar 

  • Alpha-Tocopherol, Beta Carotene Cancer Prevention Study Group. The effect of vitamin E and beta carotene on the incidence of lung cancer and other cancers in male smokers. N Engl J Med 1994; 330:1029-1035.

    Google Scholar 

  • Amann A, Corradi M, Mazzone P, Mutti A. Lung cancer biomarkers in exhaled breath. Expert Rev Mol Diagn 2011; 11:207-217.

    Article  Google Scholar 

  • Amos CI, Wu X, Broderick P, Gorlov IP, Gu J, Eisen T, et al. Genome-wide association scan of tag SNPs identifies a susceptibility locus for lung cancer at 15q25.1. Nat Genet 2008; 40:616-622.

    Google Scholar 

  • Andriani F, Conte D, Mastrangelo T, Leon M, Ratcliffe C, Roz L, et al. Detecting lung cancer in plasma with the use of multiple genetic markers. Int J Cancer 204; 108:91-96.

    Google Scholar 

  • Bach PB, Kattan MW, Thornquist MD, Kris MG, Tate RC, Barnett MJ, et al. Variations in lung cancer risk among smokers. J Natl Cancer Inst 2003; 95:470-478.

    Article  Google Scholar 

  • Baik CS, Strauss GM, Speizer FE, Feskanich D. Reproductive factors, hormone use, and risk for lung cancer in postmenopausal women, the Nurses’ Health Study. Cancer Epidemiol Biomarkers Prev 2010; 19:2525-2533.

    Article  Google Scholar 

  • Bailey-Wilson JE, Amos CI, Pinney SM, Petersen GM, de Andrade M, Wiest JS, et al. A major lung cancer susceptibility locus maps to chromosome 6q23-25. Am J Hum Genet 2004; 75:460-474.

    Article  Google Scholar 

  • Barash O, Peled N, Tisch U, Bunn PA Jr, Hirsch FR, Haick H. Classification of lung cancer histology by gold nanoparticle sensors. Nanomedicine 2011;[Epub ahead of print].

    Google Scholar 

  • Bartel DP. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 2004; 116:281-297.

    Article  Google Scholar 

  • Becker NDS, Kauczor HU. LUSI: the German component of the European trial on the efficacy of multi-slice CT for the early detection of lung cancer. Onkologie 2008; 31:320.

    Google Scholar 

  • Begum S, Brait M, Dasgupta S, Ostrow KL, Zahurak M, Carvalho AL, et al. An epigenetic marker panel for detection of lung cancer using cell-free serum DNA. Clin Cancer Res 2011; 17:4494-4503.

    Article  Google Scholar 

  • Benhamou S, Lee WJ, Alexandrie A-K, Boffetta P, Couchardy C, Butkiewicz D, et al: Meta- and pooled analyses of the effects of glutathione S-transferase M1 polymorphisms and smoking on lung cancer risk. Carcinogenesis 2002; 23:1343-1350.

    Article  Google Scholar 

  • Belinsky SA, Liechty KC, Gentry FD, Wolf HJ, Rogers J, Vu K, et al. Promoter hypermethylation of multiple genes in sputum precedes lung cancer incidence in a high-risk cohort. Cancer Res 2006; 66:3338-3344.

    Article  Google Scholar 

  • Belinsky SA, Nikula KJ, Palmisano WA, Michels R, Saccomanno G, Gabrielson E, et al. Aberrant methylation of p16(INK4a) is an early event in lung cancer and a potential biomarker for early diagnosis. Proc Natl Acad Sci U S A 1998; 95:11891-11896.

    Article  Google Scholar 

  • Berlin NI, Buncher CR, Fontana RS, Frost JK, Melamed MR. The National Cancer Institute Cooperative Early Lung Cancer Detection Program. Results of the initial screen (prevalence). Early lung cancer detection: Introduction. Am Rev Respir Dis 1984; 130:545-549.

    Google Scholar 

  • Bianchi F, Nicassio F, Marzi M, Belloni E, Dall’olio V, Bernard L, et al. A serum circulating miRNA diagnostic test to identify asymptomatic high-risk individuals with early stage lung cancer. EMBO Mol Med 2011; 3:495-503.

    Google Scholar 

  • Biomarkers Definitions Working Group. Biomarkers and surrogate endpoints: preferred definitions and conceptual framework. Clin Pharmacol Ther 2001; 69:89-95.

    Article  Google Scholar 

  • Boyle P, Chapman CJ, Holdenrieder S, Murray A, Robertson C, Wood WC, et al. Clinical validation of an autoantibody test for lung cancer. Ann Oncol 2011; 22:383-389.

    Article  Google Scholar 

  • Bremnes RM, Sirera R, Camps C. Circulating tumour-derived DNA and RNA markers in blood: a tool for early detection, diagnostics, and follow-up? Lung Cancer 2005; 49:1-12.

    Article  Google Scholar 

  • Brennan P, Hainaut P, Boffetta P. Genetics of lung-cancer susceptibility. Lancet Oncol 2011; 12:399-408.

    Article  Google Scholar 

  • Brennan P, McKay J, Moore L, Zaridze D, Mukeria A, Szeszenia-Dabrowska N, et al. Uncommon CHEK2 mis-sense variant and reduced risk of tobacco-related cancers: case control study. Hum Mol Genet 2007; 16:1794-1801.

    Article  Google Scholar 

  • Brenner DJ. Radiation risks potentially associated with low-dose CT screening of adult smokers for lung cancer. Radiology 204; 231:440-445.

    Google Scholar 

  • Brenner DR, McLaughlin JR, Hung RJ. Previous lung diseases and lung cancer risk: a systematic review and meta-analysis. PLoS One 2011; 31:e17479.

    Article  Google Scholar 

  • Brett GZ. The value of lung cancer detection by six-monthly chest radiographs. Thorax 1968; 23:414-420.

    Article  Google Scholar 

  • Brett GZ. Earlier diagnosis and survival in lung cancer. Br Med J 1969; 4:260-262.

    Article  Google Scholar 

  • Caraballoso M, Sacristan M, Serra C, Bonfill X. Drugs for preventing lung cancer in healthy people. Cochrane Database of Syst Rev 2003:CD002141.

    Google Scholar 

  • Cassidy A, Duffy SW, Myles JP, Liloglou T, Field JK. Lung cancer risk prediction: a tool for early detection. Int J Cancer 2007; 120:1-6.

    Article  Google Scholar 

  • Centers for Disease Control and Prevention (CDC). Vital signs: current cigarette smoking among adults aged >or=18 years---United States, 2005-2010. MMWR Morb Mortal Wkly Rep. 2011a; 60:1207-12.

    Google Scholar 

  • Centers for Disease Control and Prevention, Atlanta, GA. Behavioral Risk Factor Surveillance System Survey. 2011b. Available at: http://apps.nccd.cdc.gov/brfss.

    Google Scholar 

  • Centers for Disease Control and Prevention (CDC). Vital signs: nonsmokers’ exposure to seconhand smoke --- United States, 1999-2008. MMWR Morb Mortal Wkly Rep. 2010b; 59:1141-1146.

    Google Scholar 

  • Chan HP, Lewis C, Thomas PS. Exhaled breath analysis: novel approach for early detection of lung cancer. Lung Cancer 2009; 63:164-168.

    Article  Google Scholar 

  • Chao C. Associations between beer, wine, and liquor consumption and lung cancer risk: a meta-analysis. Cancer Epidemiol Biomarkers Prev 2007; 16:2436-2447.

    Article  Google Scholar 

  • Chao C, Slezak JM, Caan BJ, Quinn VP. Alcoholic beverage intake and risk of lung cancer: the California Men’s Health Study. Cancer Epidemiol Biomarkers Prev 2008; 17:2692-2699.

    Article  Google Scholar 

  • Chapman CJ, Murray A, McElveen JE, Sahin U, Luxemburger U, Türeci O, et al. Autoantibodies in lung cancer: possibilities for early detection and subsequent cure. Thorax 2008; 63:228-233.

    Article  Google Scholar 

  • Chaturvedi AK, Caporaso NE, Katki HA, Wong HL, Chatterjee N, Pine SR, et al. C-reactive protein and risk of lung cancer. J Clin Oncol 2010; 28:2719-2726.

    Article  Google Scholar 

  • Chlebowski RT, Schwartz AG, Wakelee H, Anderson GL, Stefanick ML, Manson JE, et al. Oestrogen plus progestin and lung cancer in postmenopausal women (Women’s Health Initiative trial): a post-hoc analysis of a randomised controlled trial. Lancet 2009; 374:1243-1251.

    Article  Google Scholar 

  • Church TR, National Lung Screening Trial Executive Committee. Chest radiography as the comparison for spiral CT in the National Lung Screening Trial. Acad Radiol 2003; 10:713-715.

    Google Scholar 

  • Church TR, Anderson KE, Caporaso NE, Geisser MS, Le CT, Zhang Y, et al. A prospectively measured serum biomarker for a tobacco-specific carcinogen and lung cancer in smokers. Cancer Epidemiol Biomarkers Prev 2009; 18:260-266.

    Article  Google Scholar 

  • Clark LC, Combs GF Jr, Turnbull BW, Slate EH, Chalker DK, Chow J, et al. Effects of selenium supplementation for cancer prevention in patients with carcinoma of the skin. A randomized controlled trial. Nutritional Prevention of Cancer Study Group. JAMA 1996; 276:1957-1963.

    Google Scholar 

  • Coté ML, Kardia SL, Wenzlaff AS, Ruckdeschel JC, Schwartz AG. Risk of lung cancer among white and black relatives of individuals with early-onset lung cancer. JAMA 2005; 293:3036-3042.

    Article  Google Scholar 

  • Crispo A, Brennan P, Jöckel KH, Schaffrath-Rosario A, Wichmann HE, Nyberg F, et al. The cumulative risk of lung cancer among current, ex- and never-smokers in European men. Br J Cancer 2004; 91:1280-1286.

    Article  Google Scholar 

  • Croce CM. Causes and consequences of microRNA dysregulation in cancer. Nat Rev Genet 2009; 10:704-714.

    Article  Google Scholar 

  • Darby S, Hill D, Doll R. Radon: a likely carcinogen at all exposures. Ann Oncol 2001; 12:1341-1351.

    Article  Google Scholar 

  • Dennert G, Zwahlen M, Brinkman M, Vinceti M, Zeegers MP, Horneber M. Selenium for preventing cancer. Cochrane Database Syst Rev 2011:CD005195.

    Google Scholar 

  • Diederich S, Thomas M, Semik M, Lenzen H, Roos N, Weber A, et al. Screening for early lung cancer with low-dose spiral computed tomography: results of annual follow-up examinations in asymptomatic smokers. Eur Radiol 2004; 14:691-702.

    Article  Google Scholar 

  • Doll R, Peto R. Cigarette smoking and bronchial carcinoma: dose and time relationships among regular smokers and lifelong non-smokers. J Epidemiol Community Health 1978; 32:303-313.

    Article  Google Scholar 

  • Doll R, Peto R, Boreham J, Sutherland I. Mortality in relation to smoking: 50 years’ observations on male British doctors.BMJ 2004; 328:1519 doi:10.1136/bmj.38142.554479.AE

    Article  Google Scholar 

  • Doria-Rose VP, Marcus PM, Szabo E, Tockman MS, Melamed MR, Prorok PC. Randomized controlled trials of the efficacy of lung cancer screening by sputum cytology revisited: a combined mortality analysis from the Johns Hopkins Lung Project and the Memorial Sloan-Kettering Lung Study. Cancer 2009; 115:5007-5017.

    Article  Google Scholar 

  • Dube SR, Asman K, Malarcher A, Carabollo R. Cigarette Smoking Among Adults and Trends in Smoking Cessation United States, 2008. MMWR Weekly 2009; 58:1227–1232.

    Article  Google Scholar 

  • Duffield-Lillico AJ, Reid ME, Turnbull BW, Combs GF Jr, Slate EH, Fischbach LA, et al. Baseline characteristics and the effect of selenium supplementation on cancer incidence in a randomized clinical trial: a summary report of the Nutritional Prevention of Cancer Trial. Cancer Epidemiol Biomarkers Prev 2002; 11:630-639.

    Google Scholar 

  • Dunn BK, Wagner PD, Anderson D, Greenwald P. Molecular markers for early detection. Semin Oncol 2010; 37:224-242.

    Article  Google Scholar 

  • Ebbert JO, Sood A, Hays JT, Dale LC, Hurt RD. Treating tobacco dependence: review of the best and lastest treatment options. J Thorac Oncol 2007; 2:249-256.

    Article  Google Scholar 

  • Ebbert JO, Yang P, Vachon CM, Vierkant RA, Cerhan JR, Folsom AR, et al. Lung cancer risk reduction after smoking cessation: observations from a prospective cohort of women. J Clin Oncol 2003; 21:921-926.

    Article  Google Scholar 

  • Engels EA. Inflammation in the development of lung cancer: epidemiological evidence. Expert Rev Anticancer Ther 2008; 8:605-615.

    Article  Google Scholar 

  • Evans WK, Wolfson MC. Computed tomography screening for lung cancer without a smoking cessation program--not a cost-effective idea. J Thorac Oncol 2011; 6:1781-1783.

    Article  Google Scholar 

  • Fanini F, Vannini I, Amadori D, Fabbri M. Clinical Implications of MicroRNAs in Lung Cancer. Semin Oncol 2011; 38:776-780.

    Article  Google Scholar 

  • Farlow EC, Patel K, Basu S, Lee BS, Kim AW, Coon JS, et al. Development of a multiplexed tumor-associated autoantibody-based blood test for the detection of non-small cell lung cancer. Clin Cancer Res 2010a; 16:3452-3462.

    Article  Google Scholar 

  • Farlow EC, Vercillo MS, Coon JS, Basu S, Kim AW, Faber LP, et al. A multi-analyte serum test for the detection of non-small cell lung cancer. Br J Cancer 2010b; 103:1221-1228.

    Article  Google Scholar 

  • Field JK, Smith RA, Aberle DR, Oudkerk M, Baldwin DR, Yankelevitz D, et al. International Association for the Study of Lung Cancer Computed Tomography Screening Workshop 2011 Report. J Thorac Oncol 2012; 7:10-19.

    Article  Google Scholar 

  • Fiore MC, Baker TB. Clinical practice. Treating smokers in the health care setting. N Engl J Med 2011; 365:1222-1231.

    Google Scholar 

  • Fontana RS, Sanderson DR, Woolner LB, Taylor WF, Miller WE, Muhm JR. Lung cancer screening: the Mayo Program. J Occup Med 1986; 28:746-750.

    Article  Google Scholar 

  • Foss KM, Sima C, Ugolini D, Neri M, Allen KE, Weiss GJ. miR-1254 and miR574-5p. serum-based microRNA biomarkers for early-stage non-small cell lung cancer. J Thorac Oncol 2011; 6:482-488.

    Google Scholar 

  • Friedman GD, Collen MF, Fireman BH. Multiphasic Health Checkup Evaluation: a 16-year follow-up. J Chronic Dis 1986; 39:452-463.

    Article  Google Scholar 

  • Fritz H, Kennedy D, Fergusson D, Fernandes R, Doucette S, Cooley K, et al. Vitamin A and retinoid derivatives for lung cancer: a systematic review and meta analysis. PLoS One 2011; 6:e21107.

    Article  Google Scholar 

  • Gail MH, Brinton LA, Byar DP, Corle DK, Green SB, Schairer C, et al. Projecting individualized probabilities of developing breast cancer for white females who are being examined annually. J Natl Cancer Inst 1989; 81:1879-1886.

    Article  Google Scholar 

  • Gallicchio L, Boyd K, Matanoski G, Tao XG, Chen L, Lam TK, et al. Carotenoids and the risk of developing lung cancer: a systematic review. Am J Clin Nutr 2008; 88:372-383.

    Google Scholar 

  • Gessner C, Rechner B, Hammerschmidt S, Kuhn H, Hoheisel G, Sack U, et al. Angiogenic markers in breath condensate identify non-small cell lung cancer. Lung Cancer 2010; 68:177-184.

    Article  Google Scholar 

  • Ginsberg RJ, Rubinstein LV. Randomized trial of lobectomy versus limited resection for T1 N0 non-small cell lung cancer. Lung Cancer Study Group. Ann Thorac Surg 1995; 60:615-623.

    Google Scholar 

  • Godoy MC, Naidich DP. Subsolid pulmonary nodules and the spectrum of peripheral adenocarcinomas of the lung: recommended interim guidelines for assessment and management. Radiology 2009; 253:606-622.

    Article  Google Scholar 

  • Godtfredsen NS, Prescott E, Osler M. Effect of smoking reduction on lung cancer risk. JAMA 2005; 294:1505-1510.

    Article  Google Scholar 

  • Goldstraw P, Crowley J, Chansky K, Giroux DJ, Groome PA, Rami-Porta R, et al. The IASLC Lung Cancer Staging Project: proposals for the revision of the TNM stage groupings in the forthcoming (seventh) edition of the TNM Classification of malignant tumours. J Thorac Oncol 2007; 2:706-714.

    Article  Google Scholar 

  • Govindarajan R, Ratnasinghe L, Simmons DL, Siegel ER, Midathada MV, Kim L, et al. Thiazolidinediones and the risk of lung, prostate, and colon cancer in patients with diabetes. J Clin Oncol 2007; 25:1476-1481.

    Article  Google Scholar 

  • Han KQ, Huang G, Gao CF, Wang XL, Ma B, Sun LQ, et al. Identification of lung cancer patients by serum protein profiling using surface-enhanced laser desorption/ionization time-of-flight mass spectromety. Am J Clin Oncol 2008; 31:133-139.

    Article  Google Scholar 

  • Hasegawa M, Sone S, Takashima S, Li F, Yang ZG, Maruyama Y, et al. Growth rate of small lung cancers detected on mass CT screening. Br J Radiol 2000; 73:1252-1259.

    Google Scholar 

  • Hayes JH, Anderson KE, Folsom AR. Association between nonsteroidal anti-inflammatory drug use and the incidence of lung cancer in the Iowa women’s health study.Cancer Epidemiol Biomarkers Prev 2006; 15:2226-2231.

    Article  Google Scholar 

  • Henschke CI, McCauley DI, Yankelevitz DF, Naidich DP, McGuinness G, Miettinen OS, et al. Early Lung Cancer Action Projecrt: overall design and findings from baseline screening. Lancet 1999; 354:99-105.

    Article  Google Scholar 

  • Hirsch FR, Lippman SM. Advances in the biology of lung cancer chemoprevention. J Clin Oncol 2005; 23:3186-3197.

    Article  Google Scholar 

  • Hocker JR, Peyton MD, Lerner MR, Mitchell SL, Lightfoot SA, Lander TJ, et al. Serum discrimination of early-stage lung cancer patients using electrospray-ionization mass spectrometry. Lung Cancer 2011; 74:206-211.

    Article  Google Scholar 

  • Hocking WG, Hu P, Oken MM, Winslow SD, Kvale PA, Prorok PC, et al. Lung cancer screening in the randomized Prostate, Lung, Colorectal, and Ovarian (PLCO) Cancer Screening Trial. J Natl Cancer Inst 2010; 102:722-731.

    Article  Google Scholar 

  • Humphrey LL, Teutsch S, Johnson M, U.S. Preventive Services Task Force. Lung cancer screening with sputum cytologic examination, chest radiography, and computed tomography: an update for the U.S. Preventive Services Task Force. Ann Intern Med 2004; 140:740-753.

    Google Scholar 

  • Hung RJ, McKay JD, Gaborieau V, Boffetta P, Hashibe M, Zaridze D, et al. A susceptibility locus for lung cancer maps to nicotinic acetylcholine receptor subunit genes on 15q25. Nature 2008; 452:633-637.

    Article  Google Scholar 

  • Hwang SJ, Lozano G, Amos CI, Strong LC. Germline p53 mutations in a cohort with childhood sarcoma: sex differences in cancer risk. Am J Hum Genet 2003; 72:975-983.

    Article  Google Scholar 

  • Infante M, Cavuto S, Lutman FR, Brambilla G, Chiesa G, Ceresoli G, et al. A randomized study of lung cancer screening with spiral computed tomography: three-year results from the DANTE trial. Am J Respir Crit Care Med 2009; 180:445-453.

    Article  Google Scholar 

  • International Early Lung Cancer Action Program Investigators, Henschke CI, Yankelevitz DF, Libby DM, Pasmantier MW, Smith JP, et al. Survival of patients with stage I lung cancer detected on CT screening. N Engl J Med 2006; 355:1763-1771.

    Google Scholar 

  • Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin 2011; 61:69-90.

    Article  Google Scholar 

  • Jett JR, Midthun DE. Screening for lung cancer: for patients at increased risk for lung cancer, it works. Ann Intern Med 2011; 155:540-542.

    Google Scholar 

  • Jiang F, Todd NW, Qiu Q, Liu Z, Katz RL, Stass SA. Combined genetic analysis of sputum and computed tomography for noninvasive diagnosis of non-small-cell lung cancer. Lung Cancer 2009; 66:58-63.

    Article  Google Scholar 

  • Jiang F, Todd NW, Li R, Zhang H, Fang H, Stass SA. A panel of sputum-based genomic marker for early detection of lung cancer. Cancer Prev Res (Phila). 2010; 3:1571-1578.

    Article  Google Scholar 

  • Johansson M, Relton C, Ueland PM, Vollset SE, Midttun Ø, Nygård O, et al. Seurm B vitamin levels and risk of lung cancer. JAMA 2010; 202:2377-2385.

    Article  Google Scholar 

  • Jonsson S, Thorsteinsdottir U, Gudbjartsson DF, Jonsson HH, Kristjansson K, Arnason S, et al. Familial risk of lung carcinoma in the Icelandic population. JAMA 2004; 292:2977-2983.

    Article  Google Scholar 

  • Kelley MJ, McCrory DC. Prevention of lung cancer: summary of published evidence. Chest 2003; 123:50S-59S.

    Article  Google Scholar 

  • Khuder SA, Herial NA, Mutgi AB, Federman DJ. Nonsteroidal antiinflammatory drug use and lung cancer: a metaanalysis. Chest 2005; 127:748-754.

    Article  Google Scholar 

  • Kim H, Kwon YM, Kim JS, Lee H, Park JH, Shim YM, et al. Tumor-specific methylation in bronchial lavage for the early detection of non-small-cell lung cancer. J Clin Oncol 2004; 22:2363-2370.

    Article  Google Scholar 

  • Kim DH, Park SE, Kim M, Ji YI, Kang MY, Jung EH, et al. A functional single nucleotide polymorphism at the promoter region of cyclin A2 is associated with increased risk of colon, liver, and lung cancers. Cancer 2011; 117:4080-4091.

    Article  Google Scholar 

  • Klein EA, Thompson IM Jr, Tangen CM, Crowley JJ, Lucia MS, Goodman PJ, et al. Vitamin E and the risk of prostate cancer: the Selenium and Vitamin E Cancer Prevention Trial (SELECT). JAMA 2011; 206:1549-1546.

    Article  Google Scholar 

  • Kohler BA, Ward E, McCarthy BJ, Schymura MJ, Ries LA, Eheman C, et al. Annual report to the nation on the status of cancer, 1975-2007, featuring tumors of the brain and other nervous system. J Natl Cancer Inst. 2011; 103:714-736.

    Article  Google Scholar 

  • Korte JE, Brennan P, Henley SJ, Boffetta P. Dose-specific meta-analysis and sensitivity analysis of the relation between alcohol consumption and lung cancer risk. Am J Epidemiol 2002; 155:496-506.

    Article  Google Scholar 

  • Koshiol J, Rotunno M, Consonni D, Pesatori AC, De Matteis S, Goldstein AM, et al. Chronic obstructive pulmonary disease and altered risk of lung cancer in a population-based case-control study. PLoS One 2009; 4:e7380.

    Article  Google Scholar 

  • Krewski D, Lubin JH, Zielinski JM, Alavanja M, Catalan VS, Field RW, et al. Residential radon and risk of lung cancer: a combined analysis of 7 North American case-control studies. Epidemiology 2005; 16:137-145.

    Article  Google Scholar 

  • Kubik AK, Parkin DM, Zatloukal P. Czech Study on Lung Cancer Screening: post-trial follow-up of lung cancer deaths up to year 15 since enrollment. Cancer 2000; 89:2363-2368.

    Article  Google Scholar 

  • Lam S, Boyle P, Healey GF, Maddison P, Peek L, Murray A, et al. EarlyCDT-Lung: an immunobiomarker test as an aid to early detection of lung cancer. Cancer Prev Res 2011; 4:1126-1134.

    Article  Google Scholar 

  • Lam TK, Cross AJ, Consonni D, Randi G, Bagnardi V, Bertazzi PA, et al. Intakes of red meat, processed meat, and meat mutagens increase lung cancer risk. Cancer Res 2009; 69:932-939.

    Article  Google Scholar 

  • Lam TK, Gallicchio L, Lindsley K, Shiels M, Hammond E, Tao XG, et al. Cruciferous vegetable consumption and lung cancer risk: a systematic review. Cancer Epidemiol Biomarkers Prev 2009; 18:184-195.

    Article  Google Scholar 

  • Lamy A, Sesboüé R, Bourguignon J, Dautréaux B, Métayer J, Frébourg T, et al. Aberrant methylation of the CDKN2a/p16INK4a gene promoter region in preinvasive bronchial lesions: a prospective study in high-risk patients without invasive cancer. Int J Cancer 2002; 100;189-193.

    Article  Google Scholar 

  • Landi MT, Chatterjee N, Yu K, Goldin LR, Goldstein AM, Rotunno M, et al. A genome-wide association study of lung cancer identifies a region of chromosome 5p15 associated wtih risk for adenocarcinoma. Am J Hum Genet 2009; 85:679-691.

    Article  Google Scholar 

  • Leidinger P, Keller A, Heisel S, Ludwig N, Rheinheimer S, Klein V, et al. Identification of lung cancer with high sensitivity and specificity by blood testing. Respir Res 2010; 11:18 doi:10.1186/1465-9921-11-18

    Article  Google Scholar 

  • Li R, Todd NW, Qiu Q, Fan T, Zhao RY, Rodgers WH, et al. Genetic deletions in sputum as diagnostic markers for early detection of stage I non-small cell lung cancer. Clin Cancer Res 2007; 13:482-487.

    Article  Google Scholar 

  • Lin PY, Yu SL, Yang PC. MicroRNA in lung cancer. Br J Cancer 2010; 103:1144-1148.

    Article  Google Scholar 

  • Lindell RM, Hartman TE, Swensen SJ, Jett JR, Midthun DE, Tazelaar HD, et al. Five-year lung cancer screening experience: CT appearance, growth rate, location, and histologic features of 61 lung cancers. Radiology 2007; 242:555-562.

    Article  Google Scholar 

  • Linseisen J, Rohrmann S, Miller AB, Bueno de Mesquita, B, Buchner FL, Agudo A et al. Fruits and vegetable consumption and lung cancer risk: Updated information from the European Prospective Investigation into Cancer and Nutrition (EPIC). Int J Cancer 2007; 121: 1103-1114.

    Google Scholar 

  • Lubin JH. Environmental factors in cancer: radon. Rev Environ Health 2010; 25:33-38.

    Article  Google Scholar 

  • Machado RF, Laskowski D, Deffenderfer O, Burch T, Zheng S, Mazzone PJ, et al. Detection of lung cancer by sensor array analyses of exhaled breath. Am J Respir Crit Care Med 2005; 171:1286-1291.

    Article  Google Scholar 

  • MacMahon H, Austin JH, Gamsu G, Herold CJ, Jett JR, Naidich DP, et al. Guidelines for management of small pulmonary nodules detected on CT scans: a statement from the Fleischner Society. Radiology 2005; 237:395-400.

    Article  Google Scholar 

  • Männistö S, Smith-Warner SA, Spiegelman D, Albanes D, Anderson K, van den Brandt PA, et al. Dietary carotenoids and risk of lung cancer in a pooled analysis of seven cohort studies. Cancer Epidemiol Biomarkers Prev 2004; 13:40-48.

    Article  Google Scholar 

  • Manser RL, Irving LB, Stone C, Byrnes G, Abramson M, Campbell D. Screening for lung cancer. Cochrane Database Syst Rev. 2004:CD001991.

    Google Scholar 

  • Mao JT, Roth MD, Fishbein MC,Aberle DR, Zhang ZF, Rao JY, et al. Lung cancer chemoprevention with celecoxib in former smokers. Cancer Prev Res (Phila) 2011; 4:984-993.

    Article  Google Scholar 

  • Marcus PM, Bergstralh EJ, Zweig MH, Harris A, Offord KP, Fontana RS. Extended lung cancer incidence follow-up in the Mayo Lung Project and overdiagnosis. J Natl Cancer Inst 2006; 98:748-756.

    Article  Google Scholar 

  • Matakidou A, Eisen T, Houlston RS. Systematic review of the relationship between family history and lung cancer risk. Br J Cancer 2005; 93:825-833.

    Article  Google Scholar 

  • Matthews AW. WllPoint to Cover Lung Ct Scans for Heavy Smokers. Health Blog. Wall Street Journal. December 1, 2011. Available at: blogs.wsj.com/health/2011/12/01/wellpoint-to-cover-lung-ct-scans-for-heavy-smokers/.

    Google Scholar 

  • Mattson ME, Pollack ES, Cullen JW. What are the odds that smoking will kill you? Am J Public Health 1987; 77:425-431.

    Article  Google Scholar 

  • Mayne ST, Buenconsejo J, Janerich DT. Previous lung disease and risk of lung cancer among men and women nonsmokers. Am J Epidemiol 1999; 149:13-20.

    Article  Google Scholar 

  • Mazzone PJ. Analysis of volatile organic compounds in the exhaled breath for the diagnosis of lung cancer. J Thorac Oncol 2008; 3:774-780.

    Article  Google Scholar 

  • Mazzone PJ, Hammel J, Dweik R, Na J, Czich C, Laskowski D, et al. Diagnosis of lung cancer by the analysis of exhaled breath with a colorimetric sensor array. Thorax 2007; 62:565-568.

    Article  Google Scholar 

  • Mazzone PJ, Wang XF, Xu Y, Mekhail T, Beukemann MC, Na J, Kemling JW, et al. Exhaled breath analysis with a colorimetric sensor array for the identification and characterization of lung cancer. J Thorac Oncol 2012; 7:137-142.

    Article  Google Scholar 

  • McCullough A, Fisher M, Goldstein AO, Kramer KD, Ripley-Moffitt C. Smoking as a vital sign: prompts to ask and assess increase cessation counseling. J Am Board Fam Med 2009; 22:625-632.

    Article  Google Scholar 

  • McFarlane MJ, Feinstein AR, Wells CK. Necropsy evidence of detection bias in the diagnosis of lung cancer. Arch Intern Med 1986; 146:1695-1698.

    Article  Google Scholar 

  • McMahon PM, Kong CY, Bouzan C, Weinstein MC, Cipriano LE, Tramontano AC, et al. Cost-effectiveness of computed tomography screening for lung cancer in the United States. J Thorac Oncol 2011; 6:1841-1848.

    Article  Google Scholar 

  • Melamed MR, Flehinger BJ, Zaman MB, Heelan RT, Perchick WA, Martini N. Screening for early lung cancer. Results of the Memorial Sloan-Kettering study in New York. Chest 1984; 86:44-53.

    Google Scholar 

  • Menezes RJ, Roberts HC, Paul NS, McGregor M, Chung TB, Patsios D, et al. Lung cancer screening using low-dose computed tomography in at-risk individuals: the Toronto experience. Lung Cancer 2010; 67:177-183.

    Article  Google Scholar 

  • Miller AB, Altenburg HP, Bueno-de-Mesquita B, Boshuizen HC, Agudo A, Berrino F, et al. Fruits and vegetables and lung cancer: Findings from the European Prospective Investigation into Cancer and Nutrition. Int J Cancer 2004; 108:269-276.

    Article  Google Scholar 

  • Murray A, Chapman CJ, Healey G, Peek LJ, Parsons G, Baldwin D, et al. Technical validation of an autoantibody test for lung cancer. Ann Oncol 2010; 21:1687-1693.

    Article  Google Scholar 

  • Nadich DP, Marshall CH, Gribbin C, Arams RS, McCauley DI. Low-dose CT of the lungs: preliminary observations. Radiology 1990; 175:729-731.

    Google Scholar 

  • Naruke T, Goya T, Tsuchiya R, Suemasu K. Prognosis and survival in resected lung carcinoma based on the new international staging system. J Thorac Cardiovasc Surg 1988; 96:440-447.

    Google Scholar 

  • National Lung Screening Trial Research Team, Aberle DR, Berg CD, Black WC, Church TR, Fagerstrom RM, et al. The National Lung Screening Trial: overview and study design. Radiology 2011a; 258:243-253.

    Google Scholar 

  • National Lung Screening Trial Research Team, Aberle DR, Adams AM, Berg CD, Black WC, Clapp JD, et al. Reduced lung-cancer mortality with low-dose computed tomographic screening. N Engl J Med 2011b; 365:395-409.

    Google Scholar 

  • Naurath N, Jones JM. Smoking rates around the world – how do Americans CompareF? Gallup News Service. August 17, 2007. Available at: http://www.gallup.com/poll/28432/smoking-rates-around-world-how-american-compare.aspx.

    Google Scholar 

  • NCCN Clinical Practice Guidelines in Oncology, Lung Cancer Screening, Version 1.2012, http://www.nccn.org/professionals/physician_gls/f_guidelines.asp

    Google Scholar 

  • Neuberger JS, Field RW. Occupation and lung cancer in nonsmokers. Rev Environ Health 2003; 18:251-267.

    Article  Google Scholar 

  • Oken MM, Hocking WG, Kvale PA, Andriole GL, Buys SS, Church TR, et al. Screening by chest radiograph and lung cancer mortality: the Prostate, Lung Colorectal, and Ovarian (PLCO) randomized trial. JAMA 2011; 306:1865-1873.

    Article  Google Scholar 

  • Omenn GS, Goodman G, Thornquist M, Grizzle J, Rosenstock L, Barnhart S, et al. The beta-carotene and retinol efficacy trial (CARET) for chemoprevention of lung cancer in high risk populations: smokers and asbestos-exposed workers. Cancer Res 1994; 54:2038s-2043s.

    Google Scholar 

  • Omenn GS, Goodman GE, Thornquist MD, Balmes J, Cullen MR, Glass A, et al. Effects of a combination of beta carotene and vitamin A on lung cancer and cardiovascular disease. N Engl J Med 1996; 234:1150-1155.

    Article  Google Scholar 

  • Ostrow KL, Hoque MO, Loyo M, Brait M, Greenberg A, Siegfried JM, et al. Molecular anlaysis of plasma DNA for the early detection of lung cancer by quantitative methylation-specific PCR. Clin Cancer Res 2010; 16:3463-3472.

    Article  Google Scholar 

  • Paci M, Maramotti S, Bellesia E, Formisano D, Albertazzi L, Ricchetti T, et al. Circulating plasma DNA as diagnostic biomarker in non-small cell lung cancer. Lung Cancer 2009; 64:92-97.

    Article  Google Scholar 

  • Palmisano WA, Divine KK, Saccomanno G, Gilliland FD, Baylin SB, Herman JG, et al. Predicting lung cancer by detecting aberrant promoter methylation in sputum. Cancer Res 2000; 60:5954-5958.

    Google Scholar 

  • Pastorino U, Bellomi M, Landoni C, De Fiori E, Arnaldi P, Picchio M, et al. Early lung-cancer detection with spiral CT and positron emission tomography in heavy smokers: 2-year results. Lancet 2003; 362:593-597.

    Article  Google Scholar 

  • Patz EF Jr, Campa MJ, Gottlin EB, Kusmartseva I, Guan XR, Herdon JE 2nd. Panel of serum biomarkers for the diagnosis of lung cancer. J Clin Oncol 2007; 25:5578-5583.

    Article  Google Scholar 

  • Pedersen JH, Ashraf H, Dirksen A, Bach K, Hansen H, Toennesen P, et al. The Danish randomized lung cancer CT screening trial--overall design and results of the prevalence round. J Thorac Oncol 2009; 4:608-614.

    Article  Google Scholar 

  • Pegna AL, Picozzi G, Mascalchi M, Maria Carozzi F, Carrozzi L, Comin C, et al. Design, recruitment and baseline results of the ITALUNG trial for lung cancer screening with low-dose CT. Lung Cancer 2009; 64:34-40.

    Google Scholar 

  • Peng G, Tisch U, Adams O, Hakim M, Shehada N, Broza YY, et al. Diagnosing lung cancer in exhaled breath using gold nanoparticles. Nat Nanotechno 2009; 4:669-673.

    Article  Google Scholar 

  • Phillips M, Gleeson K, Hughes JM, Greenberg J, Cataneo RN, Baker L, et al. Volatile organic compounds in breath as markers of lung cancer: a cross-sectional study. Lancet 1999; 353:1930-1933.

    Article  Google Scholar 

  • PHS Guideline Update Panel 2008, Liaisons, and Staff. Treating tobacco use and dependence: 2008 update U.S. Public Health Service Clinical Practice Guideline executive summary. Respir Care. 2008; 53:1217-1222.

    Google Scholar 

  • Pine SR, Mechanic LE, Enewold L, Chaturvedi AK, Katki HA, Zheng YL, et al. Increased levels of circulating interleukin 6, interleukin 8, C-reactive protein, and risk of lung cancer. J Natl Cancer Inst 2011; 103:1112-1122.

    Article  Google Scholar 

  • Pirkle JL, Bernert JT, Caudill SP, Sosnoff CS, Pechacek TF. Trends in the exposure of nonsmokers in the U.S. population to secondhand smoke: 1988-2002. Environ Health Perspect 2006; 114:853-858.

    Google Scholar 

  • Piper ME, Fiore MC, Smith SS, Jorenby DE, Wilson JR, Zahner ME, et al. Use of the vital sign stamp as a systematic screening tool to promote smoking cessation. Mayo Clin Proc 2003; 78:716-722.

    Article  Google Scholar 

  • Pope CA 3rd, Burnett RT, Thun MJ, Calle EE, Krewski D, Ito K, et al. Lung cancer, cardiopulmonary mortality, and long-term exposure to fi ne particulate air pollution. JAMA 2002; 287:1132-1141.

    Article  Google Scholar 

  • Prorok PC, Andriole GL, Bresalier RS, Buys SS, Chia D, Crawford ED, et al. Design of the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial. Control Clin Trials 2000; 21:273E-309S.

    Article  Google Scholar 

  • Qiu J, Choi G, Li L, Wang H, Pitteri SJ, Pereira-Faca SR, et al. Occurrence of autoantibodies to annexin I, 14-3-3 theta and LAMR1 in prediagnostic lung cancer sera. J Clin Oncol 2008;26:5060-5066.

    Article  Google Scholar 

  • Reid ME, Duffield-Lillico AJ, Garland L, Turnbull BW, Clark LC, Marshall JR. Selenium supplementation and lung cancer incidence: an update of the nutritional prevention of cancer trial. Cancer Epidemiol Biomarkers Prev 2002; 11:1285-1291.

    Google Scholar 

  • Rodriguez C, Spencer Feigelson H, Deka A, Patel AV, Jacobs EJ, Thun MJ, et al. Postmenopausal hormone therapy and lung cancer risk in the cancer prevention study II nutrition cohort. Cancer Epidemiol Biomarkers Prev 2008; 17:655-660.

    Google Scholar 

  • Samet JM, Humble CG, Pathak DR. Personal and family history of respiratory disease and lung cancer risk. Am Rev Respir Dis 1986; 134:466-470.

    Google Scholar 

  • Satia JA, Littman A, Slatore CG, Galanko JA, White E. Long-term use of beta-carotene, retinol, lycopene, and lutein supplements and lung cancer risk: results from the VITamins And Lifestyle (VITAL) study. Am J Epidemiol 2009; 169:815-828.

    Article  Google Scholar 

  • Seale JP, Shellenberger S, Velasquez MM, Boltri JM, Okosun I, Guyinn M, et al. Impact of vital signs screening & clinician prompting on alcohol and tobacco screening and intervention rates: a pre-post intervention comparison. BMC Fam Pract 2010; 11:18 doi:10:1186/1471-2296-11-18

    Article  Google Scholar 

  • Shen J, Todd NW, Zhang H, Yu L, Lingxiao X, Mei Y, et al. Plasma microRNAs as potential biomarkers for non-small-cell lung cancer. Lab Invest 2011; 91:579-587.

    Article  Google Scholar 

  • Shiels MS, Albanes D, Virtamo J, Engels EA. Increased risk of lung cancer in men with tuberculosis in the alpha-tocopherol, beta-carotene cancer prevention study. Cancer Epidemiol Biomarkers Prev 2011; 20:672-678.

    Article  Google Scholar 

  • Showe MK, Vachani A, Kossenkov AV, Yousef M, Nichols C, Nikonova EV, et al. Gene expression profiles in peripheral blood mononuclear cells can distinguish patients with non-small cell lung cancer from patients with nonmalignant lung disease. Cancer Res 2009; 69:9202-9210.

    Article  Google Scholar 

  • Siegel R, Ward E, Brawley O, Jemal A. Cancer statistics 2011: the impact of eliminating socioeconomic and racial disparities on prermature cancer deaths. CA Cancer J Clin 2011; 61:212-236.

    Article  Google Scholar 

  • Silvestri GA. Screening for lung cancer: it works, but does it really work? Ann Intern Med 2011; 155:537-539.

    Google Scholar 

  • Skillrud DM, Offord KP, Miller RD. Higher risk of lung cancer in chronic obstructive pulmonary disease. A prospective, matched, controlled study. Ann Intern Med 1986; 105:503-507.

    Google Scholar 

  • Slatore CG, Au DH, Littman AJ, Satia JA, White E . Association of nonsteroidal anti-in fl ammatory drugs with lung cancer: results from a large cohort study. Cancer Epidemiol Biomarkers Prev 2009; 18:1203-1207.

    Article  Google Scholar 

  • Slatore CG, Chien JW, Au DH, Satia JA, White E. Lung cancer and hormone replacement therapy: association in the vitamins and lifestyle study. J Clin Oncol 2010; 28:1540-1546.

    Article  Google Scholar 

  • Smith JR, Barrett-Connor E, Kritz-Silverstein D, Wingard DL, Al-Delaimy WK. Hormone use and lung cancer incidence: the Rancho Bernardo cohort study. Menopause 2009; 16:1044-1048.

    Article  Google Scholar 

  • Sobue T, Moriyama N, Kaneko M, Kusumoto M, Kobayashi T, Tsuchiya R, et al. Screening for lung cancer with low-dose helical computed tomography: anti-lung cancer association project. J Clin Oncol 2002; 20:911-920.

    Article  Google Scholar 

  • Sone S, Li F, Yang ZG, Honda T, Maruyama Y, Takashima S, et al. Results of three-year mass screening programme for lung cancer using mobile low-dose spiral computed tomography scanner. Br J Cancer 2001; 84:25-32.

    Article  Google Scholar 

  • Sozzi G, Conte D, Leon M, Ciricione R, Roz L, Ratcliffe C, et al. Quantification of free circulating DNA as a diagnostic marker in lung cancer. J Clin Oncol 2003; 21:3902-3908.

    Article  Google Scholar 

  • Sozzi G, Roz L, Conte D, Mariani L, Andriani F, Lo Vullo S, et al. Plasma DNA quantification in lung cancer computed tomography screening: five-year results of a prospective study. Am J Respir Crit Care Med 2009; 179:69-74.

    Google Scholar 

  • Spitz MR, Hong WK, Amos CI, Wu X, Schabath MB, Dong Q, et al. A risk model for prediction of lung cancer. J Natl Cancer Inst 2007; 99:715-726.

    Article  Google Scholar 

  • Sun S, Schiller JH, Gazdar AF. Lung cancer in never smokers--a different disease. Nat Rev Cancer 2007; 7:778-790.

    Article  Google Scholar 

  • Steenland K, Loomis D, Shy C, Simonsen N. Review of occupational lung carcinogens. Am J Ind Med 1996; 29:474-490.

    Article  Google Scholar 

  • Swensen SJ, Jett JR, Hartman TE, Midthun DE, Mandrekar SJ, Hillman SL, et al. CT screening for lung cancer: five-year prospective experience. Radiology 2005; 235:259-265.

    Article  Google Scholar 

  • Tammemagi CM, Pinsky PF, Caporaso NE, Kvale PA, Hocking WG, Church TR, et al. Lung cancer risk prediction: Prostate, Lung, Colorectal And Ovarian Cancer Screening Trial models and validation. J Natl Cancer Inst 2011; 103:1058-1068.

    Article  Google Scholar 

  • Taylor KL, Cox LS, Zincke N, Mehta L, McGuire C, Gelmann E. Lung cancer screening as a teachable moment for smoking cessation. Lung Cancer 2007; 56:125-134.

    Article  Google Scholar 

  • Thun MJ, Hannan LM, DeLancey JO. Alcohol consumption not associated with lung cancer mortality in lifelong nonsmokers. Cancer Epidemiol Biomarkers Prev 2009; 18:2269-2272.

    Article  Google Scholar 

  • Thun MJ, Henley SJ, Calle EE. Tobacco use and cancer: an epidemiologic perspective for geneticists. Oncogene 2002; 21:7307-7325.

    Article  Google Scholar 

  • Tockman MS. Survival and mortality from lung cancer in a screened population. The Johns Hopkins study. Chest 1986; 89(Supp 4):324S-325S.

    Google Scholar 

  • Tockman MS, Frost JK, Stitik FP, Levin ML, et al. Screening and detection of lung cancer. Vol. 3, in Contemporary Issues in Clinical Oncology, Aisner JA Ed. Philadelphia, PA; Churchill Livingstone, 1985.

    Google Scholar 

  • Toh CK, Gao F, Lim WT, Leong SS, Fong KW, Yap SP, et al. Never-smokers with lung cancer: epidemiologic evidence of a distinct disease entity. J Clin Oncol 2006; 24:2245-2251.

    Article  Google Scholar 

  • Tokuhata GK, Lilienfeld AM. Familial aggregation of lung cancer among hospital patients. Public Health Rep 1963; 78:277-283.

    Article  Google Scholar 

  • Topaloglu O, Hoque MO, Tokumaru Y, Lee J, Ratovitski E, Sidransky D, et al. Detection of promoter hypermethylation of multiple genes in the tumor and bronchoalveolar lavage of patients with lung cancer. Clin Cancer Res 2004; 10:2284-2288.

    Article  Google Scholar 

  • Townsend CO, Clark MM, Jett JR, Patten CA, Schroeder DR, Nirelli LM, et al. Relation between smoking cessation and receiving results from three annual spiral chest computed tomography scans for lung carcinoma screening. Cancer 2005; 103:2154-2162.

    Article  Google Scholar 

  • Toyoda Y, Nakayama T, Kusunoki Y, Iso H, Suzuki T. Sensitivity and specificity of lung cancer screening using chest low-dose computed tomography. Br J Cancer 2008; 98:1602-1607.

    Article  Google Scholar 

  • Tsou JA, Hagen JA, Carpenter CL, Laird-Offringa IA. DNA methylation analysis: a powerful new tool for lung cancer diagnosis. Oncogene 2002;21:5450-5461.

    Article  Google Scholar 

  • Turner MC, Chen Y, Krewski D, Callee EE, Thun MJ. Chronic obstructive pulmonary disease is associated with lung cancer mortality in a prospective study of never smokers. Am J Respir Crit Care Med 2007; 176:285-290.

    Article  Google Scholar 

  • Turner MC, Krewski D, Pope CA 3rd, Chen Y, Gapstur SM, Thun MJ. Long-term Ambient Fine Particulate Matter Air Pollution and Lung Cancer in a Large Cohort of Never-Smokers. Am J Respir Crit Care Med 2011; 184:1374-1381.

    Article  Google Scholar 

  • U.S. Department of Health and Human Services, Public Health Service. Treating Tobacco Use and Dependence. Quick Reference Guide for Clinicians: 2008 Update. April 2009. ISSN-1530-6402. Available at: http://www.ahrq.gov/clinic/tobacco/tobaqrg.pdf.

    Google Scholar 

  • U.S. Preventive Services Task Force. Lung cancer screening: recommendation statement. Ann Intern Med 2004; 140:738-739.

    Google Scholar 

  • van den Brandt PA, Goldbohm RA, van’t Veer P, Bode P, Dorant E, Hermus RJ, et al. A prospective cohort study on selenium status and the risk of lung cancer. Cancer Res 1993; 53:4860-4865.

    Google Scholar 

  • Van Dyke AL, Cote ML, Prysak G, Claeys GB, Wenzlaff AS, Schwartz AG. Regular adult aspirin use decreases the risk of non-small cell lung cancer among women. Cancer Epidemiol Biomarkers Prev 2008; 17:148-157.

    Article  Google Scholar 

  • van Iersel CA, de Koning HJ, Draisma G, Mali WP, Scholten ET, Nackaerts K, et al. Risk-based selection from the general population in a screening trial: selection criteria, recruitment and power for the Dutch-Belgian randomised lung cancer multi-slice CT screening trial (NELSON). Int J Cancer 2007; 120:868-874.

    Article  Google Scholar 

  • van Klaveren RJ, Oudkerk M, Prokop M, Scholten ET, Nackaerts K, Vernhout R, et al. Management of lung nodules detected by volume CT scanning. N Engl J Med 2009; 361:2221-2229.

    Article  Google Scholar 

  • Varella-Garcia M, Schulte AP, Wolf HJ, Feser WJ, Zeng C, Braudrick S, et al. The detection of chromosomal aneusomy by fluorescence in situ hybridization in sputum predicts lung cancer incidence. Cancer Prev Res (Phila) 2010; 3:447-453.

    Article  Google Scholar 

  • Wakelee HA, Chang ET, Gomez SL, Keegan TH, Feskanich D, Clarke CA, et al. Lung cancer incidence in never smokers. J Clin Oncol 2007; 25:472-478.

    Article  Google Scholar 

  • Wang Y, Broderick P, Webb E, Wu X, Vijayakrishnan J, Matakidou A, et al. Common 5p15.33 and 6p21.33 variants in fl uence lung cancer risk. Nat Genet 2008; 40:1407-1409.

    Google Scholar 

  • Welch HG, Black WC. Overdiagnosis in cancer. J Natl Cancer Inst 2010; 102:605-613.

    Article  Google Scholar 

  • Welch HG, Woloshin S, Schwartz LM, Gordis L, Gotzsche PC, Harris R, et al. Overstating the evidence for lung cancer screening; the International Early Lung Cancer Action Program (I-ELCAP) study. Arch Intern Med 2007; 167:2289-2295.

    Article  Google Scholar 

  • Wiener RS, Schwartz LM, Woloshin S, Welch HG. Population-based risk for complications after transthoracic needle lung biopsy of a pulmonary nodule: an analysis of discharge records.Ann Intern Med 2011; 155:137-144.

    Google Scholar 

  • Wilson DO, Weissfeld JL, Fuhrman CR, Fisher SN, Balogh P, Landreneau RJ, et al. The Pittsburgh Lung Screening Study (PLuSS): outcomes within 3 years of a first computed tomography scan. Am J Respir Crit Care Med 2008; 178:956-961.

    Article  Google Scholar 

  • Wright ME, Park Y, Subar AF, Freedman ND, Albanes D, Hollenbeck A, et al. Intakes of fruit, vegetables, and specific botanical groups in relation to lung cancer risk in the NIH-AARP Diet and Health Study. Am J Epidemiol 2008; 168:1024-1034.

    Article  Google Scholar 

  • Xie Y, Todd NW, Liu Z, Zhan M, Fang H, Peng H, et al. Altered miRNA expression in sputum for diagnosis of non-small cell lung cancer. Lung Cancer 2010; 67:170-176.

    Article  Google Scholar 

  • Xing L, Todd NW, Yu L, Fang H, Jiang F. Early detection of squamous cell lung cancer in sputum by a panel of microRNA markers. Mod Pathol 2010; 23:1157-1164.

    Article  Google Scholar 

  • Yang P, Sun Z, Krowka MJ, Aubry MC, Bamlet WR, Wampfler JA, et al. Alpha1-antitrypsin deficiency carriers, tobacco smoke, chronic obstructive pulmonary disease, and lung cancer risk. Arch Intern Med 2008; 168:1097-1103.

    Article  Google Scholar 

  • Yang WS, Va P, Wong MY, Zhang HL, Xiang YB . Soy intake is associated with lower lung cancer risk: results from a meta-analysis of epidemiologic studies. Am J Clin Nutr 2011; 94:1575-1583.

    Article  Google Scholar 

  • Yildiz PB, Shyr Y, Rahman JS, Wardwell NR, Zimmerman LJ, Shakhtour B, et al. Diagnostic accuracy of MALDI mass spectrometric analysis of unfractionated serum in lung cancer. J Thorac Oncol 2007; 2:893-901.

    Article  Google Scholar 

  • You M, Wang D, Liu P, Vikis H, James M, Lu Y, et al. Fine mapping of chromosome 6q23-25 region in familial lung cancer families reveals RGS17 as a likely candidate gene. Clin Cancer Res 2009; 15:2666-2674.

    Article  Google Scholar 

  • Yu YY, Pinsky PF, Caporaso NE, Chatterjee N, Baumgarten M, Langenberg P, et al. Lung cancer risk following detection of pulmonary scarring by chest radiography in the prostate, lung, colorectal, and ovarian cancer screening trial. Arch Intern Med 2008; 168:2326-2332.

    Article  Google Scholar 

  • Yuan JM, Koh WP, Murphy SE, Fan Y, Wang R, Carmella SG, et al. Urinary levels of tobacco-specific nitrosamine metabolites in relation to lung cancer development in two prospective cohorts of cigarette smokers. Cancer Res 2009; 69:2990-2995.

    Article  Google Scholar 

  • Zander T, Hofmann A, Staratschek-Jox A, Classen S, Debey-Pascher S, Maisel D, et al. Blood-based gene expression signatures in non-small cell lung cancer. Clin Cancer Res 2011; 17:3360-3367.

    Article  Google Scholar 

  • Zhang JJ, Smith KR. Household air pollution from coal and biomass fuels in China: measurements, health impacts, and interventions. Environ Health Perspect 2007; 115: 848-855.

    Article  Google Scholar 

  • Zhuo H, Smith AH, Steinmaus C. Selenium and lung cancer: a quantitative analysis of heterogeneity in the current epidemiological literature. Cancer Epidemiol Biomarkers Prev 2004; 13:771-778.

    Google Scholar 

  • Ziegler A, Zangemeister-Wittke U, Stahel RA. Circulating DNA: a new diagnostic gold mine? Cancer Treat Rev 2002; 28:255-271.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Marshfield Center, 1000 N Oak Ave, Marshfield, WI, 54449, USA

    William Hocking MD

Authors
  1. William Hocking MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to William Hocking MD .

Editor information

Editors and Affiliations

  1. University of Toronto, 392 Lakeshore Road East, Oakville, L6J 1J8, Ontario, Canada

    Anthony B. Miller

Rights and permissions

Reprints and permissions

Copyright information

© 2013 Springer Science+Business Media New York

About this chapter

Cite this chapter

Hocking, W. (2013). Integrating Prevention and Screening for Lung Cancer into Clinical Practice. In: Miller, A. (eds) Epidemiologic Studies in Cancer Prevention and Screening. Statistics for Biology and Health, vol 79. Springer, New York, NY. https://doi.org/10.1007/978-1-4614-5586-8_23

Download citation

Publish with us

Policies and ethics

Search

Navigation